Evidence map›Paper›PMID 23643801›Full record

ArticleToxicology and applied pharmacology2013

Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway.

Zhishan Wang, Brock Humphries, Hua Xiao, Yiguo Jiang, Chengfeng Yang

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Aryl Hydrocarbon Receptor (AHR) Suppresses Arsenic (AsInternational journal of biological sciences · 2025
    Article
  4. Article
  5. Epigenetic downregulation of OEnvironmental pollution (Barking, Essex : 1987) · 2024
    Article
  6. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Zhishan WangDepartment of Physiology, Michigan State University, East Lansing, MI 48824, USA.
Brock Humphries
Hua Xiao
Yiguo Jiang
Chengfeng Yang
Michigan State University · USGuangzhou Medical University · CN

Funding

The Epigenetic Mechanism of Arsenic Lung Carcinogenesis - Role of MicroRNAsR01ES017777 · NIEHS · MICHIGAN STATE UNIVERSITY · PI YANG, CHENGFENG · 2010 to 2014
$1.7M
NIEHS NIH HHS 1R01ES017777-01A1NIEHS NIH HHS R01 ES017777
6 · The paper itself

Abstract

Arsenic exposure represents a major health concern increasing cancer risks, yet the mechanism of arsenic carcinogenesis has not been elucidated. We and others recently reported that cell malignant transformation by arsenic is accompanied by epithelial to mesenchymal transition (EMT). However, the role of EMT in arsenic carcinogenesis is not well understood. Although previous studies showed that short term exposure of endothelial cells to arsenic stimulated angiogenesis, it remains to be determined whether cells that were malignantly transformed by long term arsenic exposure have a pro-angiogenic effect. The objective of this study was to investigate the effect of arsenic-transformed human bronchial epithelial cells that underwent EMT on angiogenesis and the underlying mechanism. It was found that the conditioned medium from arsenic-transformed cells strongly stimulated tube formation by human umbilical vein endothelial cells (HUVECs). Moreover, enhanced angiogenesis was detected in mouse xenograft tumor tissues resulting from inoculation of arsenic-transformed cells. Mechanistic studies revealed that β-catenin was activated in arsenic-transformed cells up-regulating its target gene expression including angiogenic-stimulating vascular endothelial growth factor (VEGF). Stably expressing microRNA-200b in arsenic-transformed cells that reversed EMT inhibited β-catenin activation, decreased VEGF expression and reduced tube formation by HUVECs. SiRNA knockdown β-catenin decreased VEGF expression. Adding a VEGF neutralizing antibody into the conditioned medium from arsenic-transformed cells impaired tube formation by HUVECs. Reverse transcriptase-PCR analysis revealed that the mRNA levels of canonical Wnt ligands were not increased in arsenic-transformed cells. These findings suggest that EMT in arsenic-transformed cells promotes angiogenesis through activating β-catenin-VEGF pathway.

Indexed as

AnimalsArsenicbeta CateninBronchiCell LineEpithelial CellsEpithelial-Mesenchymal TransitionGene Knockdown TechniquesHumansHuman Umbilical Vein Endothelial CellsMiceMice, NudeNeovascularization, PathologicReverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA, Small InterferingArsenicbeta CateninRNA, MessengerRNA, Small InterferingVascular Endothelial Growth Factor AAngiogenesisArsenic-transformed cellsEMTepithelial-to-mesenchymal transitionEpithelial-to-mesenchymal transition (EMT)human bronchial epithelial cells (HBECs) with p53 expression stably knocked downhuman umbilical vein endothelial cellHUVECIFimmunofluorescencemicroRNA 200bMicroRNA-200b (miR-200b)miR-200bp53(low)HBECssiRNAsmall interfering RNAvascular endothelial growth factorVEGFWntβ-Catenin

Identifiers

PMID23643801
PMCPMC3714366
OpenAlexW2036935059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.